PTGXProtagonist Therapeutics Inc

Price

$143.73

+65.21%

InvestorShares OwnedPosition ValueWeightAs Of
Stanley Druckenmiller
Duquesne Family Office
159,700$13.9M0.3%31.12.2025

This page is for educational and informational purposes only. Data is sourced from public SEC records and is not financial, investment, tax, or legal advice.